Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome

Annual Review of Medicine

Volumn 63, Issue , 2012, Pages 329-343

  Stanhope, Kimber L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fructose; Glucose; High fructose corn syrup; Insulin resistance; Lipid dysregulation; Sucrose

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACETYL COENZYME A; FRUCTOSE; GLYCERALDEHYDE 3 PHOSPHATE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN KINASE C; SUGAR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; DIETARY SUCROSE; EPIDEMICS; FRUCTOSE; HUMANS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 84855912244     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-042010-113026     Document Type: Review

References (69)

1. Dietary Guidelines Advisory Committee. 2010. Report of the Dietary Guidelines Advisory Committee (DGAC) on the Dietary Guidelines for Americans, 2010. http://www. cnpp. usda. gov/DGAs2010-DGACReport. htm
2. Johnson RK, Appel LJ, Brands M, et al. 2009. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 120:1011-20
3. Malik VS, Schulze MB, Hu FB. 2006. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am. J. Clin. Nutr. 84:274-88 (Pubitemid 44699135)
4. Mattes RD, Shikany JM, Kaiser KA, et al. 2010. Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments. Obes. Rev. 12:346-65
5. Duffey KJ, Gordon-Larsen P, Steffen LM, et al. 2010. Drinking caloric beverages increases the risk of adverse cardiometabolic outcomes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am. J. Clin. Nutr. 92:954-59
6. Welsh JA, Sharma A, Abramson JL, et al. 2010. Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303:1490-97
7. Welsh JA, Sharma A, Cunningham SA, et al. 2011. Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents. Circulation 123:249-57
8. Bremer AA, Auinger P, Byrd RS. 2010. Sugar-sweetened beverage intake trends in US adolescents and their association with insulin resistance-related parameters. J. Nutr. Metab. Epub ahead of print
9. Yoshida M, McKeown NM, Rogers G, et al. 2007. Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J. Nutr. 137:2121-27 (Pubitemid 47367275)
10. Assy N, Nasser G, Kamayse I, et al. 2008. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can. J. Gastroenterol. 22:811-16
11. Ouyang X, Cirillo P, Sautin Y, et al. 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48:993-99
12. Palmer JR, Boggs DA, Krishnan S, et al. 2008. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch. Intern. Med. 168:1487-92
13. Schulze MB, Manson JE, Ludwig DS, et al. 2004. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292:927-34 (Pubitemid 39097202)
14. Fung TT, Malik V, Rexrode KM, et al. 2009. Sweetened beverage consumption and risk of coronary heart disease in women. Am. J. Clin. Nutr. 89:1037-42
15. Dhingra R, Sullivan L, Jacques PF, et al. 2007. Soft drink consumption and risk of developing cardiometabolic risk factors and themetabolic syndrome in middle-aged adults in the community. Circulation 116:480-88 (Pubitemid 47450256)
16. Ruxton CH, Gardner EJ, McNulty HM. 2010. Is sugar consumption detrimental to health? A review of the evidence 1995-2006. Crit. Rev. Food Sci. Nutr. 50:1-19
17. Tappy L, Le KA. 2010. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 90:23-46
18. Dekker MJ, Su Q, Baker C, et al. 2010. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 299:E685-94
19. Havel PJ. 2005. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr. Rev. 63:133-57
20. Ludwig DS. 2002. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:2414-23 (Pubitemid 34495441)
21. Stanhope KL, Schwarz JM, Keim NL, et al. 2009. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119:1322-34
22. Marriott BP, Olsho L, Hadden L, et al. 2010. Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit. Rev. Food Sci. Nutr. 50:228-58
23. Wells FW, Buzby JC. 2008. Dietary assessment of major trends in US food consumption, 1970-2005. Econ. Info. Bull. US Dep. Agr. 33:18
24. Mueller WM, Gregoire FM, Stanhope KL, et al. 1998. Evidence that glucosemetabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139:551-58 (Pubitemid 28513202)
25. Teff KL, Elliott SS, Tschop M, et al. 2004. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 89:2963-72 (Pubitemid 38766393)
26. Teff KL, Grudziak J, Townsend RR, et al. 2009. Endocrine and metabolic effects of consuming fructoseand glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J. Clin. Endocrinol. Metab. 94:1562-69
27. Farooqi IS, O'Rahilly S. 2009. Leptin: a pivotal regulator of human energy homeostasis. Am. J. Clin. Nutr. 89:980S-84S
28. Morton GJ, Cummings DE, Baskin DG, et al. 2006. Central nervous system control of food intake and body weight. Nature 443:289-95 (Pubitemid 44435142)
29. Cox CL, Stanhope KL, Schwarz JM, et al. 2011. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur. J. Clin. Nutr. Epub ahead of print. doi:10. 1038/ejcn. 2011. 159
30. Stanhope KL, Havel PJ. 2008. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am. J. Clin. Nutr. 88:1733S-37S
31. Stanhope KL, Bremer AA, Medici V, et al. 2011. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J. Clin. Endocrinol. Metab. 96:E1596-605
32. Rao SS, Attaluri A, Anderson L, et al. 2007. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin. Gastroenterol. Hepatol. 5:959-63 (Pubitemid 47127024)
33. Newcomer AD, McGill DB, Thomas PJ, et al. 1975. Prospective comparison of indirect methods for detecting lactase deficiency. N. Engl. J. Med. 293:1232-36
34. Rumessen JJ, Gudmand-Hoyer E. 1986. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 27:1161-68 (Pubitemid 16002614)
35. Raben A, Vasilaras TH, Moller AC, et al. 2002. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am. J. Clin. Nutr. 76:721-29
36. Reid M, Hammersley R, Hill AJ, et al. 2007. Long-term dietary compensation for added sugar: effects of supplementary sucrose drinks over a 4-week period. Br. J. Nutr. 97:193-203 (Pubitemid 46662074)
37. Tordoff MG, Alleva AM. 1990. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am. J. Clin. Nutr. 51:963-69 (Pubitemid 20201273)
38. Raben A, Macdonald I, Astrup A. 1997. Replacement of dietary fat by sucrose or starch: effects on 14 d ad libitum energy intake, energy expenditure and body weight in formerly obese and never-obese subjects. Int. J. Obes. Relat. Metab. Disord. 21:846-59 (Pubitemid 27427473)
39. van Baak MA, Astrup A. 2009. Consumption of sugars and body weight. Obes. Rev. 10(Suppl 1):9-23
40. Fried SK, Russell CD, Grauso NL, et al. 1993. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J. Clin. Invest. 92:2191-98 (Pubitemid 23333523)
41. Stanhope KL, Griffen SC, Bremer AA, et al. 2011. Metabolic responses to prolonged consumption of glucose-and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am. J. Clin. Nutr. 94:112-19
42. Aeberli I, Gerber PA, Hochuli M, et al. 2011. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am. J. Clin. Nutr. 94:479-85
43. Hommes FA. 1993. Inborn errors of fructose metabolism. Am. J. Clin. Nutr. 58:788S-95S (Pubitemid 23319977)
44. Matsuzaka T, Shimano H, Yahagi N, et al. 2004. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53:560-69 (Pubitemid 38270623)
45. Samuel VT. 2011. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol. Metab. 22:60-65
46. Hudgins LC, Parker TS, Levine DM, et al. 2011. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J. Clin. Endocrinol. Metab. 96:861-68
47. Parks EJ, Skokan LE, Timlin MT, et al. 2008. Dietary sugars stimulate fatty acid synthesis in adults. J. Nutr. 138:1039-46 (Pubitemid 351769126)
48. Petersen KF, Laurent D, Yu C, et al. 2001. Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 50:1263-68 (Pubitemid 32500157)
49. Shiota M, Galassetti P, Monohan M, et al. 1998. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes 47:867-73 (Pubitemid 28255658)
50. McGarry JD. 1995. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem. Soc. Trans. 23:481-85
51. Le KA, Ith M, Kreis R, et al. 2009. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 89:1760-65
52. Olofsson SO, Boren J. 2005. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J. Intern. Med. 258:395-410 (Pubitemid 41546555)
53. Zheng C, Khoo C, Furtado J, et al. 2010. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 121:1722-34
54. Raben A, Holst JJ, Madsen J, Astrup A. 2001. Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal-weight never-obese and postobese women. Am. J. Clin. Nutr. 73:177-89 (Pubitemid 32109845)
55. Lopez-Miranda J, Perez-Martinez P, Marin C, et al. 2006. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr. Opin. Lipidol. 17:132-38
56. Adiels M, Taskinen MR, Packard C, et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-65 (Pubitemid 43357551)
57. Packard CJ, Shepherd J. 1997. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler. Thromb. Vasc. Biol. 17:3542-56 (Pubitemid 28028567)
58. Chapman MJ, Le Goff W, Guerin M, et al. 2010. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur. Heart J. 31:149-64
59. Packard CJ, Demant T, Stewart JP, et al. 2000. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J. Lipid. Res. 41:305-18
60. Lamarche B, Uffelman KD, Carpentier A, et al. 1999. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J. Clin. Invest. 103:1191-99 (Pubitemid 29207253)
61. Rye KA, Clay MA, Barter PJ. 1999. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145:227-38 (Pubitemid 29359129)
62. Black RN, Spence M, McMahon RO, et al. 2006. Effect of eucaloric high-and low-sucrose diets with identical macronutrient profile on insulin resistance and vascular risk: a randomized controlled trial. Diabetes 55:3566-72 (Pubitemid 44923618)
63. Marckmann P, Raben A, Astrup A. 2000. Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: effects on blood lipids, factor VII coagulant activity, and fibrinogen. Metabolism 49:731-35 (Pubitemid 30354579)
64. Reiser S, Bickard MC, Hallfrisch J, et al. 1981. Blood lipids and their distribution in lipoproteins in hyperinsulinemic subjects fed three different levels of sucrose. J. Nutr. 111:1045-57 (Pubitemid 11034746)
65. Reiser S, Hallfrisch J, Michaelis OEt, et al. 1979. Isocaloric exchange of dietary starch and sucrose in humans. I. Effects on levels of fasting blood lipids. Am. J. Clin. Nutr. 32:1659-69 (Pubitemid 9249175)
66. Stanhope KL, Havel PJ. 2008. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr. Opin. Lipidol. 19:16-24
67. Samuel VT, Petersen KF, Shulman GI. 2010. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-77
68. Reiser S, Handler HB, Gardner LB, et al. 1979. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am. J. Clin. Nutr. 32:2206-16 (Pubitemid 10206863)
69. Reiser S, Bohn E, Hallfrisch J, et al. 1981. Serum insulin and glucose in hyperinsulinemic subjects fed three different levels of sucrose. Am. J. Clin. Nutr. 34:2348-58 (Pubitemid 12176061)